Loading...
XMAD
NTH
Market cap130mUSD
Jul 09, Last price  
1.85EUR
1D
0.00%
1Q
7.56%
Jan 2017
-61.05%
IPO
-62.93%
Name

Naturhouse Health SA

Chart & Performance

D1W1MN
P/E
11.24
P/S
2.24
EPS
0.16
Div Yield, %
9.78%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-9.56%
Revenues
49m
-1.95%
59,881,00095,731,00095,792,00097,815,00094,700,00087,289,00081,667,00055,081,00057,594,00052,403,00050,407,00049,425,000
Net income
10m
-12.66%
8,544,00022,560,00022,860,00022,504,00019,855,00015,373,00013,257,0009,379,00013,361,0009,627,00011,293,0009,863,000
CFO
12m
-44.83%
7,452,00024,871,00020,946,00016,034,00016,001,00020,095,00019,677,00014,580,00016,173,0007,097,00020,950,00011,559,000
Dividend
Aug 29, 20240.081 EUR/sh

Profile

Naturhouse Health, S.A. operates in the nutrition and weight management industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. As of December 31, 2020, it operated through a network of 1,788 centers in 28 countries. The company sells its products through directly operated and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. The company was founded in 1991 and is based in Madrid, Spain.
URL
https://www.naturhouse.com/
IPO date
Apr 09, 2015
Employees
208
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
49,425
-1.95%
50,407
-3.81%
52,403
-9.01%
Cost of revenue
17,338
16,573
25,089
Unusual Expense (Income)
NOPBT
32,087
33,834
27,314
NOPBT Margin
64.92%
67.12%
52.12%
Operating Taxes
3,679
4,168
3,484
Tax Rate
11.47%
12.32%
12.76%
NOPAT
28,408
29,666
23,830
Net income
9,863
-12.66%
11,293
17.31%
9,627
-27.95%
Dividends
(12,000)
(6,000)
(18,000)
Dividend yield
6.18%
19.00%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
880
1,515
1,199
Long-term debt
5,202
6,697
5,335
Deferred revenue
Other long-term liabilities
2,037
1,641
4,189
Net debt
(25,255)
(29,174)
(16,207)
Cash flow
Cash from operating activities
11,559
20,950
7,097
CAPEX
(338)
(570)
(964)
Cash from investing activities
862
(459)
(5,218)
Cash from financing activities
(16,100)
(7,695)
(16,985)
FCF
27,639
35,077
20,284
Balance
Cash
21,673
27,098
14,775
Long term investments
9,664
10,288
7,966
Excess cash
28,866
34,866
20,121
Stockholders' equity
12,869
28,626
35,482
Invested Capital
23,896
9,881
13,609
ROIC
168.21%
252.58%
220.58%
ROCE
86.70%
87.24%
80.25%
EV
Common stock shares outstanding
59,949
59,949
Price
1.66
2.47%
1.62
2.53%
1.58
-18.13%
Market cap
97,118
2.53%
94,720
-18.13%
EV
67,950
78,565
EBITDA
34,037
36,097
29,612
EV/EBITDA
1.88
2.65
Interest
139
616
206
Interest/NOPBT
0.43%
1.82%
0.75%